(Consortium of MS Centers) Optimal use of disease-modifying therapies (DMTs) may be one of the single most important clinical decisions made in treating multiple sclerosis (MS). Currently, there are numerous DMT options and selection can be a complex issue for the clinician and patient. Patricia K. Coyle, M.D., FAAN, FANA, Director, MS Comprehensive Care Center, Stony Brook University Medical Center, will present the Donald Paty Memorial Lecture at the CMSC Annual Meeting on 'DMT-Debates - Stopping, Switching, Re-starting.'
from EurekAlert! - Social and Behavioral Science https://ift.tt/2GUaKO5
No comments:
Post a Comment